Bruker’s nuclear magnetic resonance (NMR) metabolic profiling platform has been
designed to quickly and efficiently gather qualitative and quantitative data on an individual biofluid sample which can be used to perform quality control (QC) on incoming samples, and also create a phenotype Biobank which can be offered in addition to, or instead of, sample aliquot, thus increasing the value of each sample while simultaneously reducing handling cost.